Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Financial Services · CIK 0000914208
$28.79
-1.57% · delayed ~15 min
Last price from Oct 22, 2026
$12.78B market value
From Invesco Ltd.'s FY2025 10-K, filed Feb 24, 2026 · read the filing
Invesco trades securities and runs financial markets. It took in $6.38B last year, which makes it a mid-sized company. It spends more than it earns — losing about 3 cents on every dollar of sales.
The financial picture is mixed, with growth needing attention and profitability and debt weaker.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Recent open-market selling by 4 insiders, not under a pre-arranged plan.
$7.2M sold in the last 120 days · Read the filing
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
Several areas of financial weakness.
From Invesco Ltd.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Operating income
$832.1M → -$695.7M
Profit
$538.0M → -$174.8M
Operating margin
13.7% → -10.9%
Profit margin
8.9% → -2.7%
Measured against FY2024, from the 10-K filed Feb 24, 2026
Deteriorated: turned negative
$832.1M to -$695.7MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: turned negative
$538.0M to -$174.8MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
How the latest move compares (quote delayed ~15 min), and what was published around it
IVZ fell 1.57% on the latest quote. The average Financials company tracked here moved +1.15%, and the S&P 500 −1.04%. That is 2.7 points below its sector and 0.5 points below the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 18 analysts covering this company, as of . Their views, not this site's.
Of 18 analysts publishing on this company, 1 say strong buy, 8 say buy and 9 say hold. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
The essentials
Each answered from the filings, with the numbers behind it.
No. It lost $174.8M last year, losing about 3 cents on every dollar of sales.
Slowly. Sales grew 5.1% last year.
For every $1 it owes, it owns $1.92 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors. Its operating profit does not cover its interest bill — -8.43x against the interest it owes.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It paid a dividend while making a loss, so the payment did not come out of profits — it came from reserves, borrowing or asset sales. It paid out 25% of the cash its operations generated. It has paid in each of the last 12 years.
WeakNext payment expected around , projected from how regularly it has paid before rather than from a date the company has announced.
Figures from the FY2025 annual filing
Last year it lost $174.8M and generated $1.53B of cash from operations.
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 24, 2026Filing for FY2025 | FY202410-K · Feb 25, 2025Filing for FY2024 | FY202310-K · Feb 25, 2025Filing for FY2023 | FY202210-K · Feb 25, 2025Filing for FY2022 | FY202110-K · Feb 18, 2022Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $6.38B | $6.07B | $5.72B | $6.05B | $6.89B | +5.1% |
| Selling, general and administrative | $576.5M | $594.7M | $567.6M | $493.6M | $424.1M | −3.1% |
| Operating income | -$695.7M | $832.1M | -$434.8M | $1.32B | $1.79B | n/m |
| Operating marginOperating income ÷ revenueWhat is this? | -10.9% | 13.7% | -7.6% | 21.8% | 25.9% | −24.6 pts |
| Interest expense | $82.5M | $58.0M | $70.5M | $85.2M | $94.7M | +42.2% |
| Income before tax | -$379.4M | $1.01B | -$237.9M | $1.25B | $2.50B | n/m |
| Net income | -$174.8M | $538.0M | -$333.7M | $683.9M | $1.39B | n/m |
| Net marginNet income ÷ revenueWhat is this? | -2.7% | 8.9% | -5.8% | 11.3% | 20.2% | −11.6 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $-0.3937 | $1.20 | $-0.7424 | $1.50 | $3.02 | n/m |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| IVZInvesco Ltd. · this page | 3.3/10 | 4/7 | 5.1% | -2.7% | — |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Was granted or awarded shares — 28,249 shares
Holds 53,095 shares after this filing.
Had shares withheld to cover taxes — 12,526 shares at $28.20 ($353.2K)
Holds 40,569 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Made a Regulation FD disclosure
Read the filingMade a Regulation FD disclosure
Read the filingWrite down why you are following Invesco Ltd., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 138 subsidiaries named in its 10-K, incorporated across 22 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from IVZ's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 24, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 7 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 3.3 | 4/7 | 10-K, filed Feb 24, 2026 |
| FY2024 | 6.0 | 7/7 | 10-K, filed Feb 25, 2025 |
| FY2023 | 2.0 | 3/7 | 10-K, filed Feb 21, 2024 |
| FY2022 | 6.0 | 5/7 | 10-K, filed Feb 23, 2023 |
| FY2021 | 7.3 | 5/7 | 10-K, filed Feb 18, 2022 |
| FY2020 | 6.0 | 5/7 | 10-K, filed Feb 19, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
4 of 7 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. 2 could not be evaluated and are excluded from the total rather than counted as failures.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Deteriorated: −24.6 pts
13.7% to -10.9%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: −11.6 pts
8.9% to -2.7%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: turned negative
$1.20 to -$0.39Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: +104.9%
$890.6M to $1.83BCritical
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Improved: +28.6%
$1.12B to $1.44BSignificant
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Changed: +22.0%
$69.1M to $84.3MSignificant
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Improved: +5.1%
$6.07B to $6.38BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +5.2%
$986.5M to $1.04BNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 4, 2026 — read it.
Improved: +70.0%
$214.2M to $364.2MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +71.7%
$197.4M to $338.9MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +73.4%
$0.44 to $0.77Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +20.5%
$1.52B to $1.83BSignificant
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +5.8 pts
14.1% to 19.9%Significant
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +5.5 pts
13.0% to 18.6%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: -13.8%
$1.88B to $1.62BNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Improved: -1.0%
446.0M to 441.5MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 4, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: +54.7%
$219.1M to $338.9MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +55.3%
$0.49 to $0.77Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +6.0 pts
12.6% to 18.6%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: -17.4%
$1.97B to $1.62BSignificant
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Improved: +9.3%
$333.2M to $364.2MNotable
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +13.4%
$806.9M to $915.4MNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
2 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 3.6% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 11.5x — investors pay $11.5 for each $1 of trailing profit.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Reported annual figures
| 1.15x |
| BENFRANKLIN TEMPLETON INC | 6.0/10 | 7/7 | 3.5% | 6.0% | 31.28x | 1.51x |
|---|
| Median of peers | 6.0/10 | — | 3.5% | 6.0% | 31.28x | 1.51x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Shares were sold back to the company — 8,969 shares at $28.49 ($255.5K)
Holds 173,078 shares after this filing.
Was granted or awarded shares — 16,176 shares at $28.49 ($460.9K)
Holds 189,254 shares after this filing.
Sold on the open market — 3,000 shares at $32.44 ($97.3K)
Holds 107,111 shares after this filing.
Sold on the open market — 45,095 shares at $32.28 ($1.5M)
Holds 10,205 shares after this filing.
Sold on the open market — 42,530 shares at $32.84 ($1.4M)
Holds 913,317 shares after this filing.
Sold on the open market — 100,840 shares at $32.20 ($3.2M)
Holds 812,477 shares after this filing.
Sold on the open market — 31,075 shares at $33.16 ($1.0M)
Holds 259,183 shares after this filing.
Gifted shares — 7,600 shares
Holds 251,583 shares after this filing.
Was granted or awarded shares — 13,548 shares
Holds 53,663 shares after this filing.
Had shares withheld to cover taxes — 6,331 shares at $32.78 ($207.5K)
Holds 47,332 shares after this filing.
Was granted or awarded shares — 11,891 shares
Holds 59,223 shares after this filing.
Had shares withheld to cover taxes — 5,524 shares at $32.78 ($181.1K)
Holds 53,699 shares after this filing.
Was granted or awarded shares — 22,404 shares
Holds 76,103 shares after this filing.
Had shares withheld to cover taxes — 10,358 shares at $32.78 ($339.5K)
Holds 65,745 shares after this filing.
Was granted or awarded shares — 22,642 shares
Holds 88,387 shares after this filing.
Was granted or awarded shares — 25,497 shares
Holds 46,115 shares after this filing.
Had shares withheld to cover taxes — 11,984 shares at $32.78 ($392.8K)
Holds 34,131 shares after this filing.
Was granted or awarded shares — 19,179 shares
Holds 53,310 shares after this filing.
Had shares withheld to cover taxes — 9,015 shares at $32.78 ($295.5K)
Holds 44,295 shares after this filing.
Was granted or awarded shares — 20,766 shares
Holds 65,061 shares after this filing.
Had shares withheld to cover taxes — 9,761 shares at $32.78 ($320.0K)
Holds 55,300 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 3,000 shares ($97.3K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 45,095 shares ($1.5M) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 100,840 shares ($3.2M) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 42,530 shares ($1.4M) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 31,075 shares ($1.0M) on or after .
Shares originally obtained via Restricted Stock Vesting.
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Made a Regulation FD disclosure
Had a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingMade a Regulation FD disclosure
Read the filingQuarterly report for Q2 FY2026
Revenue +20.5% · Operating margin +5.8 pts · Operating income +70.0% — against Q2 FY2025
Read the filingPublished results
Read the filingMade a Regulation FD disclosure
Read the filingMade a Regulation FD disclosure
Read the filingHeld a shareholder vote
Read the filingMade a Regulation FD disclosure
Read the filingQuarterly report for Q1 FY2026
Revenue +14.1% · Profit margin +1.4 pts · Free cash flow turned positive — against Q1 FY2025
Read the filingPublished results
Read the filingMade a Regulation FD disclosure
Read the filingProxy statement for a shareholder meeting
Read the filingMade a Regulation FD disclosure
Read the filingAnnual report for FY2025
Revenue +5.1% · Operating margin −24.6 pts · Operating income turned negative — against FY2024
Read the filingReported another event
Read the filingMade a Regulation FD disclosure
Read the filingPublished results
Read the filingThe first 40 of 138. The rest are in the exhibit.
Source: Exhibit 21 of the 10-K filed 2026-02-24. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
What Invesco (IVZ) Earnings Preview Means For Shareholders
Yahoo ·
Blackstone’s Profits Fell, but Its Stock Rose 4%. Here’s What Dividend Investors See
Yahoo ·
Blue Owl Capital Inc. (OWL) Reports Next Week: What Awaits?
Yahoo ·
CI Global Asset Management Announces Monthly Cash Distributions for October 2026 for Certain CI ETFs
Yahoo ·
Should You Invest in the Invesco KBW Bank ETF (KBWB)?
Yahoo ·
Big Pharma vs. Breakthrough Biotech: Which ETF Has More Upside for Investors?
Yahoo ·
Invesco Mortgage Capital Inc. To Announce Third Quarter 2026 Results
Yahoo ·
Forget SMH. Invesco’s Chip Fund Returned 67.69% Over the Past Year Against SMH’s 61.32%.
Yahoo ·
Nontraded REITs Raise $692M Against $117M in Redemptions
Yahoo ·
Stock Market Today: Dow Rises As Oil Prices Surge; Netflix, SpaceX Mixed Ahead Of Earnings (Live Coverage)
Yahoo ·
Invesco Q3 Earnings Coming Up: Will AUM Growth Drive Results Higher?
Yahoo ·
Invesco (IVZ) Earnings Expected to Grow: Should You Buy?
Yahoo ·
Primary sources and further research